Recommendations for the management of individuals with acquired valvular heart diseases who are involved in leisure-time physical activities or competitive sports

European Journal of Preventive Cardiology

Volumn 15, Issue 1, 2008, Pages 95-103

  Mellwig, Klaus Peter ^a   Van Buuren, Frank ^a   Gohlke Baerwolf, Christa ^b   Bjørnstad, Hans Halvor ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

heart valve disease; recommendations; sports; sports medicine

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT;

ALLOGRAFT; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; ATHLETE; BACTERIAL ENDOCARDITIS; BIOPROSTHESIS; CONNECTIVE TISSUE DISEASE; CONTACT SPORT; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; HEART ARRHYTHMIA; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART STRESS; HEART VALVE SURGERY; HUMAN; LEISURE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; PATHOGENESIS; PATIENT MONITORING; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; ROSS PROCEDURE; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE STENOSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

HEART VALVE DISEASES; HUMANS; LEISURE ACTIVITIES; PHYSICAL EXAMINATION; SEVERITY OF ILLNESS INDEX; SPORTS;

EID: 39349108016     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282ef9973     Document Type: Article

References (34)

1. Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 516–524.
2. Iung B, Gohlke-Barwolf C, Tornos P, Tribouilly C, Hall R, Butchart E, et al. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002; 23: 1252–1266.
3. Balady GJ, Weiner DA. Exercise testing for sports and the exercise prescription. Cardiol Clin 1987; 5: 183–196.
4. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 1422–1445.
5. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Baerwolf C, Lewang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231–1243.
6. Gaasch WH, Eisenhauer AC. The management of mitral valve disease. Curr Opin Cardiol 1996; 11: 114–119.
7. Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: valvular heart disease. J Am Coll Cardiol 2005; 45: 1334–1340.
8. Sanada J, Komaki S, Sannou K, Tokiwa F, Kodera K, Terada H, et al. Significance of atrial fibrillation, left atrial thrombus and severity of stenosis for risk of systemic embolism in patients with mitral stenosis. J Cardiol 1999; 33: 1–5.
9. Hatle L. Doppler echocardiographic evaluation of mitral stenosis. Cardiol Clin 1990; 8: 233–247.
10. Mohr-Kahaly S, Erbel R, Zenker G, Drexler M, Wittlich N, Schaudig M, et al. Semiquantitative grading of mitral regurgitation by color-coded Doppler echocardiography. Int J Cardiol 1989; 23: 223–230.
11. Mazur W, Nagueh SF. Echocardiographic evaluation of mitral regurgitation. Curr Opin Cardiol 2001; 16: 246–250.
12. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. A report from the American Society of Echocardiography's Nomenclature and Standards Committee and The Task Force on Valvular Regurgitation, developed in conjunction with the American College of Cardiology Echocardiography Committee, The Cardiac Imaging Committee, Council on Clinical Cardiology, The American Heart Association, and the European Society of Cardiology Working Group on Echocardiography. Eur J Echocardiogr 2003; 4: 237–261.
13. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230–268.
14. Galan A, Zoghbi WA, Quinones MA. Determination of severity of valvular aortic stenosis by Doppler echocardiography and relation of findings to clinical outcome and agreement with hemodynamic measurements determined at cardiac catheterization. Am J Cardiol 1991; 67: 1007–1012.
15. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996; 276: 199–204.
16. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990; 15: 1012–1017.
17. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome (see comments). Circulation 1997; 95: 2262–2270.
18. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617.
19. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111: 3290–3295.
20. Bonow RO, Carabello BA, Chatterjee K, De Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48: e1–e148.
21. Kim HJ, Park SW, Cho BR, Hong SH, Park PW, Hong KP. The role of cardiopulmonary exercise test in mitral and aortic regurgitation: it can predict post-operative results. Korean J Intern Med 2003; 18: 35–39.
22. Horstkotte D, Niehues R, Schulte HD, Strauer BE. Exercise capacity after heart valve replacement. Z Kardiol 1994; 83 (Suppl 3): 111–120.
23. Guerios EE, Bueno R, Nercolini D, Tarastchuk K, Andrade P, Pacheco A, et al. Mitral stenosis and percutaneous mitral valvuloplasty (part 1). J Invasive Cardiol 2005; 17: 382–386.
24. Guerios EE, Bueno R, Nercolini D, Tarastchuk K, Andrade P, Pacheco A, et al. Mitral stenosis and percutaneous mitral valvuloplasty (part 2). J Invasive Cardiol 2005; 17: 440–444.
25. Doty DB. Aortic valve replacement with homograft and autograft. Semin Thorac Cardiovasc Surg 1996; 8: 249–258.
26. Potera C. A return to football after heart surgery. Phys Sportsmed 1997; 25: 16.
27. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999; 341: 1–7.
28. Nesta F, Leyne M, Yosefy C, Simpson C, Dai D, Marshall JE, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation 2005; 112: 2022–2030.
29. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 2005; 45: 1340–1345.
30. Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987; 113: 1298–1307.
31. Furlanello F, Durante GB, Bettini R, Vergara G, Disertori M, Cozzi F, et al. Risk of arrhythmia in athletes with mitral valve prolapse. Cardiologia 1985; 30: 987–989.
32. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25: 267–276.
33. Naber CK, Al-Nawas B, Baumgartner H, Becker HJ, Block M, Erbel R, et al. Prophylaxe der infektiösen Endokarditis. Kardiologe 2007; 1: 243–250.
34. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovasular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Qaulaity of Care and Outcomes Research Interdisiciplinary Working Group. Circulation 2007; 116: 1736–1754.